| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |